Moreover, as more evidence emerges regarding the role of PAK4 in the immune evasion of cancer cells, research has evaluated the efficacy of a combination treatment of PAK4 inhibition and immune checkpoint inhibitors [34,35]. This evidence concerns the gene PAK4 and cancer.